Molecular backgrounds of ERAP1 downregulation in cervical carcinoma

Analytical Cellular Pathology

Volumn 2015, Issue , 2015, Pages

  Mehta, Akash M ^a   Osse, Michelle ^a   Kolkman Uljee, Sandra ^a   Fleuren, Gert Jan ^a   Jordanova, Ekaterina S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; DNA; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; MESSENGER RNA; RNA; UNCLASSIFIED DRUG; ERAP1 PROTEIN, HUMAN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DNA EXTRACTION; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE MICROARRAY; UTERINE CERVIX CARCINOMA; VERY ELDERLY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROSATELLITE INSTABILITY; MIDDLE AGED; UTERINE CERVIX TUMOR;

AMINOPEPTIDASES; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE INSTABILITY; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 84931046621     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.1155/2015/367837     Document Type: Article

References (30)

1. P. L. Stern, "Immunity to human papillomavirus-associated cervical neoplasia," Advances in Cancer Research, vol. 69, pp. 175-211, 1996.
2. M.-T. Heemels and H. Ploegh, "Generation, translocation, and presentation of MHC class I-restricted peptides," Annual Review of Biochemistry, vol. 64, pp. 463-491, 1995.
3. A. M. Mehta, E. S. Jordanova, G. G. Kenter, S. Ferrone, and G.-J. Fleuren, "Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma," Cancer Immunology, Immunotherapy, vol. 57, no. 2, pp. 197-206, 2008.
4. I. A. York, S.-C. Chang, T. Saric et al., "Te ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues," Nature Immunology, vol. 3, no. 12, pp. 1177-1184, 2002.
5. I. A. York, M. A. Brehm, S. Zendzian, C. F. Towne, and K. L. Rock, "Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9202-9207, 2006.
6. G. E. Hammer, F. Gonzalez, M. Champsaur, D. Cado, and N. Shastri, "Te aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules," Nature Immunology, vol. 7, no. 1, pp. 103-112, 2006.
7. J. Yan, V. V. Parekh, Y. Mendez-Fernandez et al., "In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules," Te Journal of Experimental Medicine, vol. 203, no. 3, pp. 647-659, 2006.
8. A. M. Mehta, E. S. Jordanova, T. van Wezel et al., "Genetic variation of antigen processing machinery components and association with cervical carcinoma," Genes Chromosomes and Cancer, vol. 46, no. 6, pp. 577-586, 2007.
9. A. M. Mehta, E. S. Jordanova, W. E. Corver et al., "Single nucleotide polymorphisms in antigen processing machinery component ERAP1 signifcantly associate with clinical outcome in cervical carcinoma," Genes, Chromosomes and Cancer, vol. 48, no. 5, pp. 410-418, 2009.
10. A. M. Mehta, V. M. Spaans, N. B. Mahendra et al., "Diferences in genetic variation in antigen-processing machinery components and association with cervical carcinoma risk in two Indonesian populations," Immunogenetics, vol. 67, no. 5-6, pp. 267-275, 2015.
11. E. Stratikos, A. Stamogiannos, E. Zervoudi, and D. Fruci, "A role for naturally occurring alleles of endoplasmic retic-ulum aminopeptidases in tumor immunity and cancer predisposition," Frontiers in Oncology, vol. 4, article 363, 2014.
12. B. Seliger, U. Ritz, and S. Ferrone, "Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation," International Journal of Cancer, vol. 118, no. 1, pp. 129-138, 2006.
13. W. E. Corver, N. T. ter Haar, E. J. Dreef et al., "High-resolution multi-parameter DNA fow cytometry enables detection of tumour and stromal cell subpopulations in parafn-embedded tissues," Journal of Pathology, vol. 206, no. 2, pp. 233-241, 2005.
14. E. C. A. Abeln, W. E. Corver, N. J. Kuipers-Dijkshoorn, G.-J. Fleuren, and C. J. Cornelisse, "Molecular genetic analysis of ovarian tumour cells: improved detection of loss of heterozygos-ity," British Journal of Cancer, vol. 70, no. 2, pp. 255-262, 1994.
15. R. van Eijk, M. van Puijenbroek, A. R. Chhatta et al., "Sensitive and specifc KRAS somatic mutation analysis on whole-genome amplifed DNA from archival tissues," Journal of Molecular Diagnostics, vol. 12, no. 1, pp. 27-34, 2010.
16. M. A. de Boer, E. S. Jordanova, G. G. Kenter et al., "High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients," Clinical Cancer Research, vol. 13, no. 1, pp. 132-138, 2007.
17. C. L. Andersen, J. L. Jensen, and T. F. Ørntof, "Normalization of real-time quantitative reverse transcription-PCR data: a modelbased variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets," Cancer Research, vol. 64, no. 15, pp. 5245-5250, 2004.
18. C. J. Haven, M. van Puijenbroek, M. Karperien, G.-J. Fleuren, and H. Morreau, "Diferential expression of the calcium sensing receptor and combined loss of chromosomes Iq and IIq in parathyroid carcinoma," Te Journal of Pathology, vol. 202, no. 1, pp. 86-94, 2004.
19. P. Devilee, A.-M. Cleton-Jansen, and C. J. Cornelisse, "Ever since Knudson," Trends in Genetics, vol. 17, no. 10, pp. 569-573, 2001.
20. E. Kamphausen, C. Kellert, T. Abbas et al., "Distinct molecular mechanisms leading to defcient expression of ERresident aminopeptidases in melanoma," Cancer Immunology, Immunotherapy, vol. 59, no. 8, pp. 1273-1284, 2010.
21. M. Grommé and J. Neefes, "Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways," Molecular Immunology, vol. 39, no. 3-4, pp. 181-202, 2002.
22. L. Van Kaer, "Major histocompatibility complex class I-restricted antigen processing and presentation," Tissue Antigens, vol. 60, no. 1, pp. 1-9, 2002.
23. A. Hasim, M. Abudula, R. Aimiduo et al., "Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women," PLoS ONE, vol. 7, no. 9, Article ID e44952, 2012.
24. S. Ogino, K. Nosho, N. Irahara et al., "Prognostic signifcance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers," Journal of Clinical Oncology, vol. 27, no. 27, pp. 4591-4598, 2009.
25. P. T. Campbell, E. T. Jacobs, C. M. Ulrich et al., "Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status," Journal of the National Cancer Institute, vol. 102, no. 6, pp. 391-400, 2010.
26. S. Ogino, A. T. Chan, C. S. Fuchs, and E. Giovannucci, "Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary feld," Gut, vol. 60, no. 3, pp. 397-411, 2011.
27. M. Song, R. Nishihara, M. Wang et al., "Plasma 25-hydroxy-vitamin D and colorectal cancer risk according to tumour immunity status," Gut, 2015.
28. K. Inamura, M. Yamauchi, R. Nishihara et al., "Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis," Journal of the National Cancer Institute, vol. 106, no. 9, Article ID dju195, 2014.
29. K. Inamura, M. Yamauchi, R. Nishihara et al., "Prognostic signifcance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma," Annals of Surgical Oncology, vol. 22, no. 4, pp. 1226-1235, 2015.
30. S. Ogino, P. Lochhead, A. T. Chan et al., "Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease," Modern Pathology, vol. 26, no. 4, pp. 465-484, 2013.